205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.29%
Revenue growth at 50-75% of INTC's 14.92%. Martin Whitman would worry about competitiveness or product relevance.
17.45%
Gross profit growth at 50-75% of INTC's 31.43%. Martin Whitman would question if cost structure or brand is lagging.
99.20%
EBIT growth 1.25-1.5x INTC's 80.56%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
99.20%
Operating income growth 1.25-1.5x INTC's 80.56%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
269.42%
Net income growth above 1.5x INTC's 84.93%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
271.43%
EPS growth above 1.5x INTC's 78.57%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
257.14%
Diluted EPS growth above 1.5x INTC's 78.57%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.54%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
3.44%
Diluted share count expanding well above INTC's 0.68%. Michael Burry would fear significant dilution to existing owners' stakes.
0.54%
Dividend growth above 1.5x INTC's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
34.92%
OCF growth above 1.5x INTC's 20.35%. David Dodd would confirm a clear edge in underlying cash generation.
28.24%
FCF growth 1.25-1.5x INTC's 22.60%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-3.87%
Negative 10Y revenue/share CAGR while INTC stands at 277.78%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.86%
5Y revenue/share CAGR under 50% of INTC's 19.82%. Michael Burry would suspect a significant competitive gap or product weakness.
-19.76%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
64.67%
10Y OCF/share CAGR under 50% of INTC's 392.68%. Michael Burry would worry about a persistent underperformance in cash creation.
-17.74%
Negative 5Y OCF/share CAGR while INTC is at 9.85%. Joel Greenblatt would question the firm’s operational model or cost structure.
4.61%
3Y OCF/share CAGR at 50-75% of INTC's 9.12%. Martin Whitman would suspect weaker recent execution or product competitiveness.
151.10%
Net income/share CAGR at 50-75% of INTC's 206.29%. Martin Whitman might question if the firm’s product or cost base lags behind.
147.51%
5Y net income/share CAGR above 1.5x INTC's 9.43%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-34.10%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
308.57%
10Y equity/share CAGR at 50-75% of INTC's 475.52%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
72.15%
5Y equity/share CAGR is in line with INTC's 76.46%. Walter Schloss would see parallel mid-term profitability and retention policies.
-8.05%
Negative 3Y equity/share growth while INTC is at 2.16%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
31.93%
Below 50% of INTC's 580.35%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
-1.18%
Negative 5Y dividend/share CAGR while INTC stands at 169.76%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
5.82%
3Y dividend/share CAGR above 1.5x INTC's 0.04%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
5.69%
AR growth is negative/stable vs. INTC's 15.44%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-0.50%
Inventory is declining while INTC stands at 3.39%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.09%
Asset growth at 50-75% of INTC's 5.71%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.01%
Similar to INTC's 5.40%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-4.68%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
10.38%
R&D growth drastically higher vs. INTC's 10.30%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-4.57%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.